NCT02382614终止不适用
Safety and Effectiveness of the Spiration Valve System (SVS) in Air Leaks
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 75
- 试验地点
- 40
- 主要终点
- Time to Air Leak Cessation
研究概览
简要总结
VAST is a multicenter, prospective, randomized, controlled study designed to evaluate treatment of persistent air leak with the SVS as compared to standard chest tube drainage management and other standard-of-care interventions in the control group. Eligible subjects will be randomized to receive either Spiration Valves (investigational arm) or continue standard-of-care treatment (control arm). Once the air leak has resolved, Spiration Valves should be removed.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subject has an air leak ≥ 100 mL/min, as measured by a digital thoracic drainage system (DTDS)
- •Subject has air leak present on at least the 5th day following origination.
排除标准
- •Subject has air leak only on forced exhalation or cough
- •Subject has sepsis
- •Subject has pneumonia
- •Subject has Acute Respiratory Distress Syndrome (ARDS)
- •Subject is not an appropriate candidate for, or unable to tolerate, flexible bronchoscopy procedures
- •Subject has undergone a bone marrow transplant
- •Subject has a primary pneumothorax
- •Subject has undergone a prior intervention (including pleurodesis, surgery, blood patch, and pneumoperitoneum) or valve placement.
结局指标
主要结局
Time to Air Leak Cessation
时间窗: Two weeks
次要结局
未报告次要终点
研究者
研究点 (40)
Loading locations...
相似试验
已完成
不适用
The Spiration Valve System for the Treatment of Severe EmphysemaEmpyhsemaPulmonary Disease, Chronic ObstructiveNCT01989182Olympus Corporation of the Americas107
招募中
不适用
STRIVE Post-Market Registry StudyEmphysemaNCT04302272Olympus Corporation of the Americas150
招募中
不适用
VenusP-Valve Pivotal Study (PROTEUS STUDY)Pulmonary RegurgitationNCT06010563Venus MedTech (HangZhou) Inc.60
终止
不适用
Safety and Effectiveness Study of Perceval S Valve for Extended CE MarkAortic Valve ReplacementNCT01368666Corcym S.r.l658
已完成
2 期
Pilot Study of the Spiration IBV™ SystemEmphysemaNCT00145548Olympus Corporation of the Americas91